China Pharmaceutical Equipment Industry is Expected to Reach RMB 53.22 Billion in 2016: ResearchMoz.us

ResearchMoz include new market research report”China Pharmaceutical Equipment Industry Report, 2013 – 2016: Industry Size, Shares, Growth, Trends And Forecast 2016” to its huge collection of research reports.

Browse PDF – China Pharmaceutical Equipment Industry Report, 2013 – 2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total profit of China’s pharmaceutical equipment industry both have increased significantly, and the revenue achieved a year-on-year growth rate of 51.5%, 28.2% and 26% in 2010-2012 respectively.

However, restricted by the actual progress of new GMP certification and market capacity, the revenue growth of China’s pharmaceutical equipment industry will slow down in 2013-2016, probably at an annual average growth rate of 20% or so, and the revenue is expected to reach RMB 53.22 billion in 2016.

Due to a wide range of pharmaceutical equipment product categories and a customized business model generally adopted by enterprises, there is no one or a few pharmaceutical equipment companies capable of controlling the entire market, the industry concentration is low, the majority of enterprises are small and medium-sized, and the market concentration is low (20%≤CR8<40%).

Browse Full Report With Complete TOC ahttp://www.researchmoz.us/china-pharmaceutical-equipment-industry-report-2013-2016-report.html

Shinva Medical Instrument Co., Ltd. is a leading sterilization equipment company in China. Its revenue from medical equipment (including pharmaceutical equipment) was RMB 2.408 billion in 2012 and RMB 1.524 billion in the first half of 2013. According to the statistics of China Association for Pharmaceutical Equipment, Shinva sold 10,048 units of sterilization equipment in 2012 and 7,873 units in the first 11 months of 2013, accounting for 86.8% and 84.3% of the total sales volume respectively.

Shanghai Tofflon Science and Technology Co., Ltd. is the leader in China’s freeze-drying system industry, and realized revenue of RMB 822 million in 2012, accounting for 3.3% of China’s pharmaceutical equipment market; in China’s freeze-dryer market, it occupied a market share of 50-60% by sales in 2012 and 2013.

Truking Technology Limited is a major supplier of liquid injection pharmaceutical equipment in China, its revenue in 2012 was RMB 589 million, occupying 2.3% of China’s pharmaceutical equipment market; in 2012, it accounted for 29.2% of the infusion device market by sales volume. Hunan China Sun Pharmaceutical Machinery Co., Ltd. is also an important supplier of injection pharmaceutical equipment in China, its revenue in 2012 was RMB 365 million, holding 1.4% of China’s pharmaceutical equipment market; in 2012, it contributed 19.1% of the sales volume in the infusion device market.

Related Reports – 

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 – CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 – CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth.” The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in 2012 to almost $4.5 billion in 2019. This equates to a Compound Annual Growth Rate (CAGR) of 30.4%. Novel treatments with disease-modifying mechanisms of action are the primary factor driving the growth of the value of the market. The positive impact of new market entrants will offset the effects of key patent losses during the forecast period.

View Full Report With Complete TOC at http://www.researchmoz.us/cystic-fibrosis-therapeutics-in-major-developed-markets-to-2019-cftr-modulators-initiate-drive-towards-personalized-treatment-and-market-growth-report.html

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 – Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 – Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be driven by a rising treatment population and the continued uptake of biologics. Biologics will continue to drive market growth despite leading brands Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab) losing patent protection in most of the major markets over the forecast period. Although the market will suffer revenue losses as a result of sales erosion from biosimilar competitors, this will be offset by the emergence of novel therapies. Most notably, these include monoclonal antibodies secukinumab, ixekizumab and brodalumab, which are currently being developed by Alcon (Novartis subsidiary), Eli Lilly and Amgen, respectively.

View Full Report With Complete TOC at http://www.researchmoz.us/systemic-psoriasis-therapeutics-in-major-developed-markets-to-2020-continued-uptake-of-biologics-and-novel-pipeline-drugs-to-drive-growth-description-report.html\

Glucose Monitoring Device Market to 2019 – Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers

“Glucose Monitoring Device Market to 2019 – Technology adoption and increasing health awareness serve as distinct regional growth drivers” looks at the market, competitive landscape, and trends for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

View Full Report With Complete TOC at http://www.researchmoz.us/glucose-monitoring-device-market-to-2019-technology-adoption-and-increasing-health-awareness-serve-as-distinct-regional-growth-drivers-report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Website@ http://www.researchmoz.us/
Email: sales@researchmoz.us

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s